Clinical trial
Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate
NCT00040456 · Baylor College of Medicine, Other · Terminated
Key facts
| NCT number | NCT00040456 |
|---|---|
| Title | Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate |
| Official title | The Effect of Oral Magnesium Pidolate on Incidence of Painful Crises in Patients With Hemoglobin SC Disease |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | Boston Children's Hospital |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HEMOGLOBIN SC DISEASE |
| Intervention type | Drug |
| Interventions | Mg Pidolate, Placebo |
| Enrollment | 12 |
| Start date | Jan 1, 2001 |
| Completion | May 1, 2006 |
| First posted | Jun 28, 2002 |
| Last update posted | Nov 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: